Anthony J. Dolisi
Corporate Officer/Principal bij GENEREX BIOTECHNOLOGY CORPORATION
Profiel
Anthony J.
Dolisi currently works at Olaregen Therapeutix, Inc., as President & Chief Executive Officer from 2018 and Generex Biotechnology Corp., as Chief Commercial Officer from 2019.
Actieve functies van Anthony J. Dolisi
| Bedrijven | Functie | Begin |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Corporate Officer/Principal | 08-01-2019 |
Olaregen Therapeutix, Inc.
 Olaregen Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Olaregen Therapeutix, Inc. develops and manufactures regenerative medicines. The firm offers Excellagen, a topically applied product for dermal wounds and other indications. The company was founded in 2017 and is headquartered in New York, NY. | Algemeen Directeur | 01-01-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
Olaregen Therapeutix, Inc.
Olaregen Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Olaregen Therapeutix, Inc. develops and manufactures regenerative medicines. The firm offers Excellagen, a topically applied product for dermal wounds and other indications. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
